Colitis ulcerosa: nyitott vizsgálatok itt: Lengyelország

In Lengyelország 48 Also abroad 382

48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.

2. fázisToborozResearch participation
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Where
Bydgoszcz, Chorzow, Cracow, Lodz, Lublin, Opole, Poznan, Rzeszow, Rzeszów, Sopot, Szczecin, Torun, Tychy, Wadowice, Warsaw, Warszawa, Wroclaw, Wrocław, Zamość
Age
18 év and over
People
593 worldwide
Run by
Eli Lilly & Co.
See details and how to join2023-507853-13-00EU 2023-507853-13-00Regiszter frissítve: 2026-11-09
2. fázisCsak meghívásosTrial-stage medicine
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Bydgoszcz, Cracow, Katowice, Klodzko, Lodz, Opole, Poznan, Rzeszow, Sopot, Staszów, Szczecin, Tychy, Warsaw, Wroclaw
Age
18 év and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294EU 2025-524640-35-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Katowice, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zamość
Age
18 év to 70 év
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Where
Katowice, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Zamość
Age
18 év to 80 év
People
252 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07186101Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Chorzów, Katowice, Kielce, Krakow, Lodz, Malbork, Nowy Targ, Poznan, Siedlce, Szczecin, Tychy, Warsaw, Zamość
Age
18 év to 80 év
People
1431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Where
Cracow, Katowice, Lublin, Poznan, Siedlce, Szczecin, Warsaw, Warszawa, Zamość
Age
18 év to 80 év
People
60 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07483073EU 2025-524112-11-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Where
Cracow, Katowice, Lodz, Lublin, Poznan, Szczecin, Warsaw, Warszawa, Wloclawek, Wroclaw
Age
18 év and over
People
1380 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06651281EU 2024-513533-20-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Rzeszów, Sosnowiec, Warsaw
Age
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332EU 2023-509560-16-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Bydgoszcz, Cracow, Lublin, Olsztyn, Opole, Rzeszow, Szczecin, Torun, Tychy, Warsaw, Wroclaw, Zamość
Age
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856EU 2026-525923-26-00Regiszter frissítve: 2026-11-03
4. fázisToborozResearch participation
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Where
Radom, Warsaw
People
16 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522362-78-00EU 2025-522362-78-00Regiszter frissítve: 2026-10-30
1/2. fázisToborozTrial-stage medicine
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
Bydgoszcz, Katowice, Krakow, Nowy Targ, Sopot, Staszów, Szczecin, Warsaw, Wroclaw
Age
18 év to 75 év
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990Regiszter frissítve: 2026-10-30
2. fázisToborozTrial-stage medicine
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Where
Cracow, Katowice, Lodz, Szczecin, Warsaw, Wroclaw
Age
12 év to 17 év
People
36 worldwide
Run by
Pfizer
See details and how to joinNCT05287126EU 2022-500345-25-00Regiszter frissítve: 2026-10-27
2. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
Bydgoszcz, Chojnice, Cracow, Grudziadz, Katowice, Knurów, Nowy Targ, Opole, Poznan, Skierniewice, Szczecin, Warsaw, Wroclaw, Zamość
Age
18 év and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336EU 2025-520690-39-00Regiszter frissítve: 2026-10-27
2. fázisToborozTrial-stage medicine
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Bydgoszcz, Cracow, Katowice, Klodzko, Lodz, Opole, Poznan, Rzeszow, Sopot, Staszów, Szczecin, Tychy, Warsaw, Wroclaw
Age
18 év to 75 év
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395EU 2025-521242-26-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Bialystok, Warsaw
Age
2 év to 17 év
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519EU 2024-514695-41-00Regiszter frissítve: 2026-10-27
3. fázisToborozResearch participation
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Where
Bydgoszcz, Lodz, Rzeszów, Warsaw
Age
Up to 17 év
People
68 worldwide
Run by
Alfasigma S.p.A.
See details and how to join2024-511458-32-00EU 2024-511458-32-00Regiszter frissítve: 2026-10-26
2. fázisToborozTrial-stage medicine
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Where
Cracow, Katowice, Warsaw
Age
2 év to 11 év
People
24 worldwide
Run by
Pfizer
See details and how to joinNCT07470879EU 2025-523100-77-00Regiszter frissítve: 2026-10-26
3. fázisToborozTrial-stage medicine
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Elblag, Katowice, Krakow, Lodz, Poznan, Rzeszów, Sopot, Staszów, Szczecin, Wadowice, Warsaw, Wrocklaw
Age
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996Regiszter frissítve: 2026-10-23
2. fázisToborozTrial-stage medicine
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Where
Cracow, Szczecin, Warsaw, Wroclaw
Age
18 év to 75 év
People
100 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07463183EU 2025-523479-49-00Regiszter frissítve: 2026-10-23
2. fázisToborozResearch participation
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Where
Chorzow, Cracow, Katowice, Kielce, Lodz, Malbork, Nowy Targ, Poznan, Siedlce, Szczecin, Tychy, Warsaw, Warszawa, Zamość
Age
18 év and over
People
104 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-524404-29-00EU 2025-524404-29-00Regiszter frissítve: 2026-10-21
2. fázisToborozTrial-stage medicine
Confirmatory Clinical Study in Active Ulcerative Colitis
Where
Bydgoszcz, Cracow, Czestochowa, Katowice, Leczna, Lodz, Lublin, Nowy Targ, Olsztyn, Opole, Piotrkow Trybunalski, Poznan, Sopot, Szczecin, Torun, Tychy, Warsaw, Wroclaw
Age
16 év and over
People
204 worldwide
Run by
MRM Health NV
See details and how to joinNCT07296315EU 2025-524682-24-00Regiszter frissítve: 2026-10-21
2. fázisToborozTrial-stage medicine
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Bydgoszcz, Elblag, Katowice, Kielce, Kłodzko, Krakow, Lodz, Lublin, Nowy Targ, Opole, Poznan, Sopot, Staszów, Szczecin, Torun, Tychy, Warsaw, Wroclaw
Age
18 év to 75 év
People
204 worldwide
Run by
Palisade Bio
See details and how to joinNCT07845487Regiszter frissítve: 2026-10-21
2/3. fázisToborozTrial-stage medicine
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Where
Gdansk, Krakow, Lodz, Rzeszów, Szczecin, Warsaw, Wroclaw
Age
2 év to 17 év
People
120 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05076175Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Where
Bydgoszcz, Lodz, Rzeszów, Warsaw
Age
8 év to 18 év
People
80 worldwide
Run by
Alfasigma S.p.A.
See details and how to joinNCT06865417Regiszter frissítve: 2026-10-20
1/2. fázisToborozTrial-stage medicine
A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Where
Katowice, Warsaw, Wroclaw
Age
18 év to 75 év
People
100 worldwide
Run by
Mage Biologics
See details and how to joinNCT07374471EU 2025-524719-35-00Regiszter frissítve: 2026-10-20

Minden vizsgálat (Colitis ulcerosa) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek